Acorda Therapeutics (ACOR:NAS) Fundamental Valuation Report
Fundamental Valuation Report Acorda Therapeutics(ACOR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.74 (USD) 28/02/2019 Weighted Valuation$21.10 (USD) Overall RatingUndervalued by 43.2% Valuation Models Analyst Consensus: $23.67 (USD) (in …
Acorda Therapeutics (ACOR:NAS) Fundamental Valuation Report Read more »
Read More